Metastasis on bone scan with low prostate specific antigen (≤20 ng/ml) and Gleason's score (<8) in newly diagnosed Pakistani males with prostate cancer: should we follow Western guidelines?
To find out diagnostic correlation of prostate specific antigen (PSA) and Gleason' s score (GS) with bone metastasis (BM) in newly diagnosed prostate cancer (PC) patients in Pakistan. This retrospective study included 204 newly diagnosed PC patients who were referred for BS for staging. The mean age, mean PSA and incidence of BM on BS were 71±09 years, 111.0±58.5 ng/ml and 67/204 (33%), respectively. The mean GS of the studied population was 7±1. According to PSA levels, patients were divided into 5 groups: <10 ng/ml (77/204), >10-≤20 ng/ml (4/204), >20-≤50 ng/ml (22/204), >50-≤100 (25/204) and >100 ng/ml (38/204). The incidence of positive BS (%) for BM and mean GS (score ±SD) for each group were 14%, 7±1; 10%, 6±1; 32%, 7±1; 56%, 8∓1 and 82%, 8±1 respectively (significant p value). PSA and GS were statistically significant predictors of BM on BS and their predictive value was additive (p<0.0001). Age was not a predictive factor (non-significant p value). Sensitivity and specificity of PSA at a cut-off 48 ng/ml were 68.3% and 86.1% respectively, while GS at a cut-off>6 was more sensitive (88.9%) and less specific (56.2%) for diagnosing BM. (1) There is an overall increased incidence of BM in newly diagnosed patients with PC and even at serum PSA level≤20 ng/ml and GS<8; (2) PSA and GS are independent predictors for BM but age is not; (3) in view of possible aggressive behavior of PC in local population, one must be careful in adopting Western guidelines for using BS in newly diagnosed Asian males with PC having PSA≤20 ng/ml and GS <8.